Clinical Trial Update: Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety and efficacy of early deferiprone treatment in infants and young children with beta-thalassemia major anemia and iron overload…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: Chiesi Canada Corp | Conditions: Beta Thalassemia Major Anemia, Iron Overload | Phase 4 | Status: COMPLETED | Results posted: 2024-03-15